Made Edgard Rurus Surya Erlangga
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Made Edgard Rurus Surya Erlangga has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Aldhi Pradana Hernugrahanto
Division of Interventional Cardiology, Department of Cardiology and Vascular Medicine, Faculty of Medicine Universitas Airlangga, Dr. Soetomo General Academic Hospital, Surabaya 60286, Indonesia
2 shared publications - Budi Baktijasa Dharmadjati
Division of Arrhythmia, Electrophysiology and Pacing, Department of Cardiology and Vascular Medicine, Faculty of Medicine Universitas Airlangga, Dr. Soetomo General Academic Hospital, Surabaya 60286, Indonesia
2 shared publications - David Nugraha
Faculty of Medicine, Universitas Airlangga
2 shared publications - I. Gde Rurus Suryawan
Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia
2 shared publications - Mochamad Yusuf Alsagaff
Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia Department of Cardiology and Vascular Medicine, Universitas Airlangga Hospital, Surabaya, Indonesia
2 shared publications - Pandit Bagus Tri Saputra
Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Airlangga, Jl. Prof. DR. Moestopo No.47, Pacar Kembang, Kec. Tambaksari, Surabaya, East Java 60132, Indonesia
2 shared publications
Latest Publications
- Open Access
- 4 March 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (5) , 1716
RURUS SURYAWAN Score: A Novel Scoring System to Predict 30-Day Mortality for Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
Background/Objectives: It is essential to identify acute myocardial infarction patients with greater risk of deterioration following primary percutaneous coronary intervention. Due to an inconsistent result about predictors of 30-day outcomes regarding scoring systems for the first episode of acute myocardial infarction, the objective of this study is to develop novel scoring systems to predict 30-day mortality among patients with a first episode of acute myocardial infarction who underwent primary percutaneous coronary intervention. Methods: This retrospective study was conducted with total sampling for all patients with first-time acute myocardial infarction who underwent primary percutaneous coronary intervention between 2021 and 2024 at Dr. Soetomo Hospital, Indonesia. We performed a total sampling and collected 1714 patients, of which 1535 patients were included. Our primary outcomes included 30-day mortality. Results: The analysis included 1535 patients: 926 in the derivation set and 609 in the validation set. In our study, the 30-day mortality rate was 20.7%. Multivariate logistic regression analysis was used to build prediction models in the derivation group and then validated in the validation cohort. The area under the ROC curve of the RURUS SURYAWAN score to predict 30-day mortality was 0.944 (0.906–0.972) in the derivation set and 0.959 (0.921–0.983) in the validation set, with 94.6% sensitivity and 97.3% specificity (p < 0.001). Conclusions: After adjusting for potential confounders, we developed RURUS SURYAWAN, a novel scoring system to identify predictors of 30-day mortality among acute myocardial infarction before primary percutaneous coronary intervention.
- 4 March 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (5) , 1716
Open AccessRURUS SURYAWAN Score: A Novel Scoring System to Predict 30-Day Mortality for Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
Background/Objectives: It is essential to identify acute myocardial infarction patients with greater risk of deterioration following primary percutaneous coronary intervention. Due to an inconsistent result about predictors of 30-day outcomes regarding scoring systems for the first episode of acute myocardial infarction, the objective of this study is to develop novel scoring systems to predict 30-day mortality among patients with a first episode of acute myocardial infarction who underwent primary percutaneous coronary intervention. Methods: This retrospective study was conducted with total sampling for all patients with first-time acute myocardial infarction who underwent primary percutaneous coronary intervention between 2021 and 2024 at Dr. Soetomo Hospital, Indonesia. We performed a total sampling and collected 1714 patients, of which 1535 patients were included. Our primary outcomes included 30-day mortality. Results: The analysis included 1535 patients: 926 in the derivation set and 609 in the validation set. In our study, the 30-day mortality rate was 20.7%. Multivariate logistic regression analysis was used to build prediction models in the derivation group and then validated in the validation cohort. The area under the ROC curve of the RURUS SURYAWAN score to predict 30-day mortality was 0.944 (0.906–0.972) in the derivation set and 0.959 (0.921–0.983) in the validation set, with 94.6% sensitivity and 97.3% specificity (p < 0.001). Conclusions: After adjusting for potential confounders, we developed RURUS SURYAWAN, a novel scoring system to identify predictors of 30-day mortality among acute myocardial infarction before primary percutaneous coronary intervention.
- Open Access
- 26 December 2024
- Published by MDPI AG in Preprints.org
RURUS SURYAWAN Score: A Novel Scoring System to Predict 30-Day Mortality for Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
Background/Objectives: It is essential to identify acute myocardial infarction patients with greater risk of deterioration following primary percutaneous coronary intervention. Given an inconsistent result about predictors of 30-day outcomes regarding scoring system for first episode of acute myocardial infarction, the objective of this study is to develop novel scoring system to predict 30-day mortality among patients with first episode of acute myocardial infarction underwent primary percutaneous coronary intervention. Methodology. Retrospective study was conducted with total sampling for all patients with first-time acute myocardial infarction underwent primary percutaneous coronary intervention, between 2021 to 2024 at Dr. Soetomo Hospital, Indonesia. We performed a total sampling, collected 1714 patients, in which 1535 patients were included.. Primary outcomes were 30-day mortality. Results. The analysis included 1535 patients: derivation set 926 and validation set 609. In our study, the 30-day mortality was 20.7%. Multivariate logistic regression analysis was used to build prediction models in derivation group, and then validated in validation cohort. Discrimination, calibration and clinical usefulness of the predicting model were assessed using the C-index, calibration plot and decision curve analysis. After pairwise comparison, the best performing model was chosen to build a nomogram according to the regression coefficients. The AUROC was 0.944 (0.906–0.972) in the derivation set and 0.959 (0.921–0.983) in the validation set. Conclusion. After adjusting for potential confounders, we developed RURUS SURYAWAN, a novel scoring system to identify predictor of 30-day mortality among acute myocardial infarction before primary percutaneous coronary intervention.
- 26 December 2024
- Published by MDPI AG in Preprints.org
Open AccessRURUS SURYAWAN Score: A Novel Scoring System to Predict 30-Day Mortality for Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
Background/Objectives: It is essential to identify acute myocardial infarction patients with greater risk of deterioration following primary percutaneous coronary intervention. Given an inconsistent result about predictors of 30-day outcomes regarding scoring system for first episode of acute myocardial infarction, the objective of this study is to develop novel scoring system to predict 30-day mortality among patients with first episode of acute myocardial infarction underwent primary percutaneous coronary intervention. Methodology. Retrospective study was conducted with total sampling for all patients with first-time acute myocardial infarction underwent primary percutaneous coronary intervention, between 2021 to 2024 at Dr. Soetomo Hospital, Indonesia. We performed a total sampling, collected 1714 patients, in which 1535 patients were included.. Primary outcomes were 30-day mortality. Results. The analysis included 1535 patients: derivation set 926 and validation set 609. In our study, the 30-day mortality was 20.7%. Multivariate logistic regression analysis was used to build prediction models in derivation group, and then validated in validation cohort. Discrimination, calibration and clinical usefulness of the predicting model were assessed using the C-index, calibration plot and decision curve analysis. After pairwise comparison, the best performing model was chosen to build a nomogram according to the regression coefficients. The AUROC was 0.944 (0.906–0.972) in the derivation set and 0.959 (0.921–0.983) in the validation set. Conclusion. After adjusting for potential confounders, we developed RURUS SURYAWAN, a novel scoring system to identify predictor of 30-day mortality among acute myocardial infarction before primary percutaneous coronary intervention.